APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposomal Amphoteracin B

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liposomal Amphoteracin B Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchLiposomal Amphoteracin B Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposomal Amphoteracin B Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Liposomal Amphoteracin B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposomal Amphoteracin B Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposomal Amphoteracin B Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Liposomal Amphoteracin B market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liposomal Amphoteracin B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liposomal Amphoteracin B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liposomal Amphoteracin B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liposomal Amphoteracin B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Liposomal Amphoteracin B include Gilead Sciences and Cipla etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liposomal Amphoteracin B, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liposomal Amphoteracin B, also provides the sales of main regions and countries. Of the upcoming market potential for Liposomal Amphoteracin B, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liposomal Amphoteracin B sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liposomal Amphoteracin B market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liposomal Amphoteracin B sales, projected growth trends, production technology, application and end-user industry.

Liposomal Amphoteracin B Segment by Company

Gilead Sciences

Cipla

Liposomal Amphoteracin B Segment by Type

25mg

50mg

Liposomal Amphoteracin B Segment by Application

Hospital

Pharmacy

Liposomal Amphoteracin B Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposomal Amphoteracin B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposomal Amphoteracin B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposomal Amphoteracin B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liposomal Amphoteracin B in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liposomal Amphoteracin B manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomal Amphoteracin B sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liposomal Amphoteracin B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 25mg Major Manufacturers Table 3. 50mg Major Manufacturers Table 4. Global Liposomal Amphoteracin B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Liposomal Amphoteracin B Industry Trends Table 8. Liposomal Amphoteracin B Industry Drivers Table 9. Liposomal Amphoteracin B Industry Opportunities and Challenges Table 10. Liposomal Amphoteracin B Industry Restraints Table 11. Global Liposomal Amphoteracin B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Liposomal Amphoteracin B Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Liposomal Amphoteracin B Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Liposomal Amphoteracin B Revenue Market Share by Region (2021-2026) Table 15. Global Liposomal Amphoteracin B Revenue Market Share by Region (2027-2032) Table 16. Global Liposomal Amphoteracin B Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Liposomal Amphoteracin B Sales by Region (2021-2026) & (K Units) Table 18. Global Liposomal Amphoteracin B Sales by Region (2027-2032) & (K Units) Table 19. Global Liposomal Amphoteracin B Sales Market Share by Region (2021-2026) Table 20. Global Liposomal Amphoteracin B Sales Market Share by Region (2027-2032) Table 21. Global Liposomal Amphoteracin B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Liposomal Amphoteracin B Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Liposomal Amphoteracin B Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Liposomal Amphoteracin B Sales Market Share by Manufacturers (2021-2026) Table 25. Global Liposomal Amphoteracin B Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Liposomal Amphoteracin B Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Liposomal Amphoteracin B Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Liposomal Amphoteracin B Manufacturers, Product Type & Application Table 29. Global Liposomal Amphoteracin B Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Liposomal Amphoteracin B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Liposomal Amphoteracin B Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Liposomal Amphoteracin B Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Liposomal Amphoteracin B Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Liposomal Amphoteracin B Revenue Market Share by Type (2021-2026) Table 36. Global Liposomal Amphoteracin B Revenue Market Share by Type (2027-2032) Table 37. Global Liposomal Amphoteracin B Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Liposomal Amphoteracin B Sales by Type (2021-2026) & (K Units) Table 39. Global Liposomal Amphoteracin B Sales by Type (2027-2032) & (K Units) Table 40. Global Liposomal Amphoteracin B Sales Market Share by Type (2021-2026) Table 41. Global Liposomal Amphoteracin B Sales Market Share by Type (2027-2032) Table 42. Global Liposomal Amphoteracin B Price by Type (2021-2026) & (US$/Unit) Table 43. Global Liposomal Amphoteracin B Price by Type (2027-2032) & (US$/Unit) Table 44. Global Liposomal Amphoteracin B Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Liposomal Amphoteracin B Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Liposomal Amphoteracin B Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Liposomal Amphoteracin B Revenue Market Share by Application (2021-2026) Table 48. Global Liposomal Amphoteracin B Revenue Market Share by Application (2027-2032) Table 49. Global Liposomal Amphoteracin B Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Liposomal Amphoteracin B Sales by Application (2021-2026) & (K Units) Table 51. Global Liposomal Amphoteracin B Sales by Application (2027-2032) & (K Units) Table 52. Global Liposomal Amphoteracin B Sales Market Share by Application (2021-2026) Table 53. Global Liposomal Amphoteracin B Sales Market Share by Application (2027-2032) Table 54. Global Liposomal Amphoteracin B Price by Application (2021-2026) & (US$/Unit) Table 55. Global Liposomal Amphoteracin B Price by Application (2027-2032) & (US$/Unit) Table 56. Gilead Sciences Company Information Table 57. Gilead Sciences Business Overview Table 58. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Gilead Sciences Liposomal Amphoteracin B Product Portfolio Table 60. Gilead Sciences Recent Development Table 61. Cipla Company Information Table 62. Cipla Business Overview Table 63. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Cipla Liposomal Amphoteracin B Product Portfolio Table 65. Cipla Recent Development Table 66. North America Liposomal Amphoteracin B Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Liposomal Amphoteracin B Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Liposomal Amphoteracin B Sales by Type (2021-2026) & (K Units) Table 69. North America Liposomal Amphoteracin B Sales by Type (2027-2032) & (K Units) Table 70. North America Liposomal Amphoteracin B Sales Price by Type (2021-2026) & (US$/Unit) Table 71. North America Liposomal Amphoteracin B Sales Price by Type (2027-2032) & (US$/Unit) Table 72. North America Liposomal Amphoteracin B Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Liposomal Amphoteracin B Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Liposomal Amphoteracin B Sales by Application (2021-2026) & (K Units) Table 75. North America Liposomal Amphoteracin B Sales by Application (2027-2032) & (K Units) Table 76. North America Liposomal Amphoteracin B Sales Price by Application (2021-2026) & (US$/Unit) Table 77. North America Liposomal Amphoteracin B Sales Price by Application (2027-2032) & (US$/Unit) Table 78. North America Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Liposomal Amphoteracin B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Liposomal Amphoteracin B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 82. North America Liposomal Amphoteracin B Sales by Country (2021-2026) & (K Units) Table 83. North America Liposomal Amphoteracin B Sales by Country (2027-2032) & (K Units) Table 84. North America Liposomal Amphoteracin B Sales Price by Country (2021-2026) & (US$/Unit) Table 85. North America Liposomal Amphoteracin B Sales Price by Country (2027-2032) & (US$/Unit) Table 86. United States Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 87. Canada Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 88. Europe Liposomal Amphoteracin B Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Liposomal Amphoteracin B Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Liposomal Amphoteracin B Sales by Type (2021-2026) & (K Units) Table 91. Europe Liposomal Amphoteracin B Sales by Type (2027-2032) & (K Units) Table 92. Europe Liposomal Amphoteracin B Sales Price by Type (2021-2026) & (US$/Unit) Table 93. Europe Liposomal Amphoteracin B Sales Price by Type (2027-2032) & (US$/Unit) Table 94. Europe Liposomal Amphoteracin B Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Liposomal Amphoteracin B Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Liposomal Amphoteracin B Sales by Application (2021-2026) & (K Units) Table 97. Europe Liposomal Amphoteracin B Sales by Application (2027-2032) & (K Units) Table 98. Europe Liposomal Amphoteracin B Sales Price by Application (2021-2026) & (US$/Unit) Table 99. Europe Liposomal Amphoteracin B Sales Price by Application (2027-2032) & (US$/Unit) Table 100. Europe Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Liposomal Amphoteracin B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. Europe Liposomal Amphoteracin B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. Europe Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. Europe Liposomal Amphoteracin B Sales by Country (2021-2026) & (K Units) Table 105. Europe Liposomal Amphoteracin B Sales by Country (2027-2032) & (K Units) Table 106. Europe Liposomal Amphoteracin B Sales Price by Country (2021-2026) & (US$/Unit) Table 107. Europe Liposomal Amphoteracin B Sales Price by Country (2027-2032) & (US$/Unit) Table 108. Germany Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 109. France Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 110. U.K. Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 111. Italy Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 113. Nordic Countries Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 114. China Liposomal Amphoteracin B Revenue by Type (2021-2026) & (US$ Million) Table 115. China Liposomal Amphoteracin B Revenue by Type (2027-2032) & (US$ Million) Table 116. China Liposomal Amphoteracin B Sales by Type (2021-2026) & (K Units) Table 117. China Liposomal Amphoteracin B Sales by Type (2027-2032) & (K Units) Table 118. China Liposomal Amphoteracin B Sales Price by Type (2021-2026) & (US$/Unit) Table 119. China Liposomal Amphoteracin B Sales Price by Type (2027-2032) & (US$/Unit) Table 120. China Liposomal Amphoteracin B Revenue by Application (2021-2026) & (US$ Million) Table 121. China Liposomal Amphoteracin B Revenue by Application (2027-2032) & (US$ Million) Table 122. China Liposomal Amphoteracin B Sales by Application (2021-2026) & (K Units) Table 123. China Liposomal Amphoteracin B Sales by Application (2027-2032) & (K Units) Table 124. China Liposomal Amphoteracin B Sales Price by Application (2021-2026) & (US$/Unit) Table 125. China Liposomal Amphoteracin B Sales Price by Application (2027-2032) & (US$/Unit) Table 126. Asia Liposomal Amphoteracin B Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Liposomal Amphoteracin B Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Liposomal Amphoteracin B Sales by Type (2021-2026) & (K Units) Table 129. Asia Liposomal Amphoteracin B Sales by Type (2027-2032) & (K Units) Table 130. Asia Liposomal Amphoteracin B Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Asia Liposomal Amphoteracin B Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Asia Liposomal Amphoteracin B Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Liposomal Amphoteracin B Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Liposomal Amphoteracin B Sales by Application (2021-2026) & (K Units) Table 135. Asia Liposomal Amphoteracin B Sales by Application (2027-2032) & (K Units) Table 136. Asia Liposomal Amphoteracin B Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Asia Liposomal Amphoteracin B Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Asia Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Liposomal Amphoteracin B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Liposomal Amphoteracin B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Asia Liposomal Amphoteracin B Sales by Country (2021-2026) & (K Units) Table 143. Asia Liposomal Amphoteracin B Sales by Country (2027-2032) & (K Units) Table 144. Asia Liposomal Amphoteracin B Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Asia Liposomal Amphoteracin B Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Japan Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 147. South Korea Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 148. India Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 149. Australia Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 150. China Taiwan Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Liposomal Amphoteracin B Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Liposomal Amphoteracin B Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Liposomal Amphoteracin B Sales by Type (2021-2026) & (K Units) Table 155. SAMEA Liposomal Amphoteracin B Sales by Type (2027-2032) & (K Units) Table 156. SAMEA Liposomal Amphoteracin B Sales Price by Type (2021-2026) & (US$/Unit) Table 157. SAMEA Liposomal Amphoteracin B Sales Price by Type (2027-2032) & (US$/Unit) Table 158. SAMEA Liposomal Amphoteracin B Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Liposomal Amphoteracin B Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Liposomal Amphoteracin B Sales by Application (2021-2026) & (K Units) Table 161. SAMEA Liposomal Amphoteracin B Sales by Application (2027-2032) & (K Units) Table 162. SAMEA Liposomal Amphoteracin B Sales Price by Application (2021-2026) & (US$/Unit) Table 163. SAMEA Liposomal Amphoteracin B Sales Price by Application (2027-2032) & (US$/Unit) Table 164. SAMEA Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Liposomal Amphoteracin B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Liposomal Amphoteracin B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. SAMEA Liposomal Amphoteracin B Sales by Country (2021-2026) & (K Units) Table 169. SAMEA Liposomal Amphoteracin B Sales by Country (2027-2032) & (K Units) Table 170. SAMEA Liposomal Amphoteracin B Sales Price by Country (2021-2026) & (US$/Unit) Table 171. SAMEA Liposomal Amphoteracin B Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Brazil Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 173. Argentina Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 174. Chile Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 175. Colombia Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 176. Peru Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 178. Israel Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 179. UAE Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 180. Turkey Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 181. Iran Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 182. Egypt Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Liposomal Amphoteracin B Distributors List Table 186. Liposomal Amphoteracin B Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Liposomal Amphoteracin B Image Figure 2. Global Liposomal Amphoteracin B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposomal Amphoteracin B Market Size Share 2021 VS 2025 VS 2032 Figure 4. 25mg Image Figure 5. 50mg Image Figure 6. Global Liposomal Amphoteracin B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liposomal Amphoteracin B Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Liposomal Amphoteracin B Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Liposomal Amphoteracin B Revenue (2021-2032) & (US$ Million) Figure 12. Global Liposomal Amphoteracin B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Liposomal Amphoteracin B Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Liposomal Amphoteracin B Revenue Market Share by Region (2021-2032) Figure 15. Global Liposomal Amphoteracin B Sales (2021-2032) & (K Units) Figure 16. Global Liposomal Amphoteracin B Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Liposomal Amphoteracin B Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Liposomal Amphoteracin B Sales YoY (2021-2032) & (K Units) Figure 19. Europe Liposomal Amphoteracin B Sales YoY (2021-2032) & (K Units) Figure 20. China Liposomal Amphoteracin B Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Liposomal Amphoteracin B Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Liposomal Amphoteracin B Sales YoY (2021-2032) & (K Units) Figure 23. Global Liposomal Amphoteracin B Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Liposomal Amphoteracin B Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Liposomal Amphoteracin B Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Liposomal Amphoteracin B Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Liposomal Amphoteracin B Revenue Market Share by Type (2021-2032) Figure 29. Global Liposomal Amphoteracin B Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Liposomal Amphoteracin B Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Liposomal Amphoteracin B Sales Market Share by Type (2021-2032) Figure 32. Global Liposomal Amphoteracin B Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Liposomal Amphoteracin B Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Liposomal Amphoteracin B Revenue Market Share by Application (2021-2032) Figure 35. Global Liposomal Amphoteracin B Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Liposomal Amphoteracin B Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Liposomal Amphoteracin B Sales Market Share by Application (2021-2032) Figure 38. North America Liposomal Amphoteracin B Revenue Share by Type (2021-2032) Figure 39. North America Liposomal Amphoteracin B Sales Share by Type (2021-2032) Figure 40. North America Liposomal Amphoteracin B Revenue Share by Application (2021-2032) Figure 41. North America Liposomal Amphoteracin B Sales Share by Application (2021-2032) Figure 42. North America Liposomal Amphoteracin B Revenue Share by Country (2021-2032) Figure 43. North America Liposomal Amphoteracin B Sales Share by Country (2021-2032) Figure 44. Europe Liposomal Amphoteracin B Revenue Share by Type (2021-2032) Figure 45. Europe Liposomal Amphoteracin B Sales Share by Type (2021-2032) Figure 46. Europe Liposomal Amphoteracin B Revenue Share by Application (2021-2032) Figure 47. Europe Liposomal Amphoteracin B Sales Share by Application (2021-2032) Figure 48. Europe Liposomal Amphoteracin B Revenue Share by Country (2021-2032) Figure 49. Europe Liposomal Amphoteracin B Sales Share by Country (2021-2032) Figure 50. China Liposomal Amphoteracin B Revenue Share by Type (2021-2032) Figure 51. China Liposomal Amphoteracin B Sales Share by Type (2021-2032) Figure 52. China Liposomal Amphoteracin B Revenue Share by Application (2021-2032) Figure 53. China Liposomal Amphoteracin B Sales Share by Application (2021-2032) Figure 54. Asia Liposomal Amphoteracin B Revenue Share by Type (2021-2032) Figure 55. Asia Liposomal Amphoteracin B Sales Share by Type (2021-2032) Figure 56. Asia Liposomal Amphoteracin B Revenue Share by Application (2021-2032) Figure 57. Asia Liposomal Amphoteracin B Sales Share by Application (2021-2032) Figure 58. Asia Liposomal Amphoteracin B Revenue Share by Country (2021-2032) Figure 59. Asia Liposomal Amphoteracin B Sales Share by Country (2021-2032) Figure 60. SAMEA Liposomal Amphoteracin B Revenue Share by Type (2021-2032) Figure 61. SAMEA Liposomal Amphoteracin B Sales Share by Type (2021-2032) Figure 62. SAMEA Liposomal Amphoteracin B Revenue Share by Application (2021-2032) Figure 63. SAMEA Liposomal Amphoteracin B Sales Share by Application (2021-2032) Figure 64. SAMEA Liposomal Amphoteracin B Revenue Share by Country (2021-2032) Figure 65. SAMEA Liposomal Amphoteracin B Sales Share by Country (2021-2032) Figure 66. Liposomal Amphoteracin B Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Liposomal Amphoteracin B Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg
  • 50mg
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Gilead Sciences
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liposomal Amphoteracin B Market by Type
  3. 1.2.1 Global Liposomal Amphoteracin B Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 25mg
  5. 1.2.3 50mg
  6. 1.3 Liposomal Amphoteracin B Market by Application
  7. 1.3.1 Global Liposomal Amphoteracin B Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Liposomal Amphoteracin B Market Dynamics
  1. 2.1 Liposomal Amphoteracin B Industry Trends
  2. 2.2 Liposomal Amphoteracin B Industry Drivers
  3. 2.3 Liposomal Amphoteracin B Industry Opportunities and Challenges
  4. 2.4 Liposomal Amphoteracin B Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liposomal Amphoteracin B Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liposomal Amphoteracin B Revenue by Region
  3. 3.2.1 Global Liposomal Amphoteracin B Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liposomal Amphoteracin B Revenue by Region (2021-2026)
  5. 3.2.3 Global Liposomal Amphoteracin B Revenue by Region (2027-2032)
  6. 3.2.4 Global Liposomal Amphoteracin B Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liposomal Amphoteracin B Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liposomal Amphoteracin B Sales by Region
  9. 3.4.1 Global Liposomal Amphoteracin B Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liposomal Amphoteracin B Sales by Region (2021-2026)
  11. 3.4.3 Global Liposomal Amphoteracin B Sales by Region (2027-2032)
  12. 3.4.4 Global Liposomal Amphoteracin B Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liposomal Amphoteracin B Revenue by Manufacturers
  2. 4.1.1 Global Liposomal Amphoteracin B Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liposomal Amphoteracin B Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liposomal Amphoteracin B Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liposomal Amphoteracin B Sales by Manufacturers
  6. 4.2.1 Global Liposomal Amphoteracin B Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liposomal Amphoteracin B Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liposomal Amphoteracin B Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liposomal Amphoteracin B Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liposomal Amphoteracin B Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liposomal Amphoteracin B Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liposomal Amphoteracin B Manufacturers, Product Type & Application
  13. 4.7 Global Liposomal Amphoteracin B Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liposomal Amphoteracin B Market CR5 and HHI
  16. 4.8.2 2025 Liposomal Amphoteracin B Tier 1, Tier 2, and Tier 3
5 Liposomal Amphoteracin B Market by Type
  1. 5.1 Global Liposomal Amphoteracin B Revenue by Type
  2. 5.1.1 Global Liposomal Amphoteracin B Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liposomal Amphoteracin B Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liposomal Amphoteracin B Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liposomal Amphoteracin B Sales by Type
  6. 5.2.1 Global Liposomal Amphoteracin B Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liposomal Amphoteracin B Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Liposomal Amphoteracin B Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liposomal Amphoteracin B Price by Type
6 Liposomal Amphoteracin B Market by Application
  1. 6.1 Global Liposomal Amphoteracin B Revenue by Application
  2. 6.1.1 Global Liposomal Amphoteracin B Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liposomal Amphoteracin B Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liposomal Amphoteracin B Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liposomal Amphoteracin B Sales by Application
  6. 6.2.1 Global Liposomal Amphoteracin B Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liposomal Amphoteracin B Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Liposomal Amphoteracin B Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liposomal Amphoteracin B Price by Application
7 Company Profiles
  1. 7.1 Gilead Sciences
  2. 7.1.1 Gilead Sciences Company Information
  3. 7.1.2 Gilead Sciences Business Overview
  4. 7.1.3 Gilead Sciences Liposomal Amphoteracin B Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Gilead Sciences Liposomal Amphoteracin B Product Portfolio
  6. 7.1.5 Gilead Sciences Recent Developments
  7. 7.2 Cipla
  8. 7.2.1 Cipla Company Information
  9. 7.2.2 Cipla Business Overview
  10. 7.2.3 Cipla Liposomal Amphoteracin B Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cipla Liposomal Amphoteracin B Product Portfolio
  12. 7.2.5 Cipla Recent Developments
8 North America
  1. 8.1 North America Liposomal Amphoteracin B Market Size by Type
  2. 8.1.1 North America Liposomal Amphoteracin B Revenue by Type (2021-2032)
  3. 8.1.2 North America Liposomal Amphoteracin B Sales by Type (2021-2032)
  4. 8.1.3 North America Liposomal Amphoteracin B Price by Type (2021-2032)
  5. 8.2 North America Liposomal Amphoteracin B Market Size by Application
  6. 8.2.1 North America Liposomal Amphoteracin B Revenue by Application (2021-2032)
  7. 8.2.2 North America Liposomal Amphoteracin B Sales by Application (2021-2032)
  8. 8.2.3 North America Liposomal Amphoteracin B Price by Application (2021-2032)
  9. 8.3 North America Liposomal Amphoteracin B Market Size by Country
  10. 8.3.1 North America Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liposomal Amphoteracin B Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Liposomal Amphoteracin B Market Size by Type
  2. 9.1.1 Europe Liposomal Amphoteracin B Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liposomal Amphoteracin B Sales by Type (2021-2032)
  4. 9.1.3 Europe Liposomal Amphoteracin B Price by Type (2021-2032)
  5. 9.2 Europe Liposomal Amphoteracin B Market Size by Application
  6. 9.2.1 Europe Liposomal Amphoteracin B Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liposomal Amphoteracin B Sales by Application (2021-2032)
  8. 9.2.3 Europe Liposomal Amphoteracin B Price by Application (2021-2032)
  9. 9.3 Europe Liposomal Amphoteracin B Market Size by Country
  10. 9.3.1 Europe Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liposomal Amphoteracin B Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Liposomal Amphoteracin B Market Size by Type
  2. 10.1.1 China Liposomal Amphoteracin B Revenue by Type (2021-2032)
  3. 10.1.2 China Liposomal Amphoteracin B Sales by Type (2021-2032)
  4. 10.1.3 China Liposomal Amphoteracin B Price by Type (2021-2032)
  5. 10.2 China Liposomal Amphoteracin B Market Size by Application
  6. 10.2.1 China Liposomal Amphoteracin B Revenue by Application (2021-2032)
  7. 10.2.2 China Liposomal Amphoteracin B Sales by Application (2021-2032)
  8. 10.2.3 China Liposomal Amphoteracin B Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liposomal Amphoteracin B Market Size by Type
  2. 11.1.1 Asia Liposomal Amphoteracin B Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liposomal Amphoteracin B Sales by Type (2021-2032)
  4. 11.1.3 Asia Liposomal Amphoteracin B Price by Type (2021-2032)
  5. 11.2 Asia Liposomal Amphoteracin B Market Size by Application
  6. 11.2.1 Asia Liposomal Amphoteracin B Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liposomal Amphoteracin B Sales by Application (2021-2032)
  8. 11.2.3 Asia Liposomal Amphoteracin B Price by Application (2021-2032)
  9. 11.3 Asia Liposomal Amphoteracin B Market Size by Country
  10. 11.3.1 Asia Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liposomal Amphoteracin B Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liposomal Amphoteracin B Market Size by Type
  2. 12.1.1 SAMEA Liposomal Amphoteracin B Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liposomal Amphoteracin B Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liposomal Amphoteracin B Price by Type (2021-2032)
  5. 12.2 SAMEA Liposomal Amphoteracin B Market Size by Application
  6. 12.2.1 SAMEA Liposomal Amphoteracin B Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liposomal Amphoteracin B Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liposomal Amphoteracin B Price by Application (2021-2032)
  9. 12.3 SAMEA Liposomal Amphoteracin B Market Size by Country
  10. 12.3.1 SAMEA Liposomal Amphoteracin B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liposomal Amphoteracin B Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liposomal Amphoteracin B Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liposomal Amphoteracin B Value Chain Analysis
  2. 13.1.1 Liposomal Amphoteracin B Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liposomal Amphoteracin B Production Mode & Process
  6. 13.2 Liposomal Amphoteracin B Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liposomal Amphoteracin B Distributors
  9. 13.2.3 Liposomal Amphoteracin B Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst